The Time is Right to Set Sail—The Launch Conference of Ruihe Pharmaceutical’s Third Business Division Concluded Successfully

On June 2, 2026, Guizhou Ruihe Pharmaceutical Co., Ltd. marked a significant milestone in its development: the launch conference of its Third Business Division was successfully held at the company’s headquarters. With the theme “Co‑construction, Co‑sharing, and Win‑win,” the event brought together the company’s senior marketing executives and provincial/regional heads, with all 15 attendees in attendance, signaling a solid step forward for Ruihe Pharmaceutical in building its marketing system and expanding its presence in the end‑user market.

With far-sighted vision, we will jointly build three major pillars.

The meeting commenced under the chairmanship of Chen Zhongqiang, Director of the Third Business Division. Chairman Xiong Yigang delivered the opening address, articulating in depth the three core pillars of pharmaceutical company development: a robust sales force, a strong product portfolio, and sustained R&D capabilities. He emphasized that these three elements are mutually reinforcing and indispensable.

In the face of the widespread industry challenges confronting pharmaceutical companies today, President Xiong emphasized the need to proactively explore a collaborative model that ensures long-term value for market‑building partners, establishing a marketing partnership framework grounded in shared cultural values, underpinned by an integrated, omni‑channel system, and aimed at co‑creating sustainable growth. Using a vivid analogy, he inspired the audience: “A company is the fertile soil in which ideas take root; products are seeds brimming with potential; and the sales team are the diligent artisans who bring it all to life.” With the current moment presenting an unparalleled window of opportunity, Ruihe Pharmaceutical stands ready to join hands with every partner, deepen its market presence, and build a brighter future together.

Strategic Leadership, Cultural Soul-Building

General Manager Zhao Yun then provided a comprehensive overview of the company’s historical evolution, strategic roadmap, and corporate culture. From its humble beginnings marked by arduous exploration to its current position of establishing core strengths across multiple therapeutic areas, Ruihe Pharmaceutical has consistently adhered to a business philosophy rooted in product excellence and driven by innovation. Looking ahead, the company will continue to strengthen its product portfolio, expand its market presence, and enhance its distribution channels, thereby forging a more competitive growth trajectory.

General Manager Zhao emphasized that corporate culture serves as the spiritual bond that unites the team and attracts partners. Ruihe Pharmaceutical champions core values of openness, pragmatism, and collaboration, striving to guide every partner from contractual alignment to cultural resonance, thereby fostering a genuine sense of belonging and confidence in long-term growth.

Products reign supreme; the market lays the foundation.

Zheng Mingguang, Director of the Medical Marketing Department, conducted an in-depth market analysis of the key products under the Third Business Unit, with a particular focus on introducing… Oral Ulcer Powder including Kechuanning, Miao Zhai Jingutong Plaster, Compound Heiguteng Cervical Pain Patch, and Lingzhi Capsules. He systematically analyzed each product—covering its disease‑related context, market performance, product positioning, and core competitive advantages—thereby demonstrating the competitive potential of Ruihe’s offerings in the end‑user market.

Among them, the oral ulcer powder, as one of the dual flagship products, has become a focal point of discussion. In response to key issues of concern in the frontline market, provincial general managers actively offered constructive suggestions and formulated several pragmatic measures. Furthermore, General Manager Xiong used licorice tablets as an analogy to underscore the importance of forging a path for proprietary brands, rather than merely following trends.

Clear goals, decisive action.

Director Chen Zhongqiang provided a detailed overview of the Third Business Division’s organizational structure, operational mechanisms, management systems, and three-year strategic plan, with clearly defined sales targets and a well-articulated business strategy. As 2026 marks the inaugural year, the priority is to develop high‑potential markets and achieve the set sales objectives. The goals are both ambitious and highly attainable.

The meeting also outlined supporting measures, including internet platform governance and a traceability‑code system, to ensure the healthy functioning of market order and safeguard the long-term interests of all partners.

Pooling wisdom and strength, forging consensus.

During the plenary remarks by provincial representatives, leaders from the three northeastern provinces, as well as from Gansu, Shandong, Shanxi, Hubei, Jiangxi, Sichuan, Chongqing, Guangdong, and other regions, each offered their views. Participants generally expressed strong approval of the product portfolio and the company’s strategic direction, while also raising issues of particular concern. The meeting addressed these points one by one, resulting in actionable solutions.

Notably, several provincial federation presidents openly acknowledged that this conference has given them a fresh understanding of the Ruihe brand’s product value, significantly boosting their confidence. The Sichuan provincial president remarked, “Our previous knowledge was far from comprehensive; today, we have truly witnessed Ruihe’s strength and sincerity.” Meanwhile, the Guangdong provincial president stated, “We hope the cooperation framework will deliver lasting value, fostering not only contractual agreements but also a genuine sense of belonging.”

Institutional safeguards ensure steady progress and long-term success.

To ensure the effective implementation of the strategy, the meeting established a three-tier regular‑meeting system: weekly business‑learning sessions, monthly sales meetings, and an annual summary conference, thereby fostering smooth information flow and efficient decision‑making. At the conclusion of the meeting, seven resolutions were adopted, serving as a guiding framework for the future actions of the Third Business Division.

Conclusion

This launch conference is not merely a work‑deployment meeting; it is also a rallying call to align thinking, unite efforts, and bolster confidence. Guided by this meeting, the Third Business Division of Guizhou Ruihe Pharmaceutical will take root at the point of sale, pursue meticulous cultivation, and, in close collaboration with partners across all provinces and regions, write a new chapter for Ruihe in the vast landscape of the national pharmaceutical market.

Now is the time to set sail; a shared future awaits us today.

[Contributed by: Zheng Mingguang, Zhang Shuhua]